Skip to main content
Premium Trial:

Request an Annual Quote

Solexa's Revenues Fall 21 Percent as Firm Winds Down MPSS Service, Launches Early-Access Sequencers

NEW YORK (GenomeWeb News) - Solexa yesterday reported a 21-percent drop in second-quarter revenues as it started winding down its MPSS service business and shipped its first early-access DNA sequencers.
The company reported $1.1 million in revenues for the quarter ended June 30, down from $1.4 million during the same quarter a year ago. Most of the revenue came from Solexa’s MPSS service business, and the year-over-year decline was due to reducing this service, which Solexa plans to phase out by the end of the year.
Solexa's revenues do not yet include proceeds from sales of DNA sequencing instruments.
Solexa’s R&D expenses for the quarter climbed to $5.5 million, from $4.7 million during the same period a year ago. This increase was related to higher costs for personnel and material, including building and operating several prototype instruments, as well as stock-based compensation.
The company’s quarterly net loss widened slightly to $9.8 million from $9.4 million in the year-ago period.
As of June 30, Solexa had $58.1 million in cash and cash equivalents.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.